Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pneumococcal vaccination. Assessment and prospects]

C Lafaix1

  • 1Service des Maladies Infectieuses et Tropicales (Faculté de médecine de Créteil), Centre Hospitalier Intercommunal, Villeneuve Saint Georges.

Bulletin De L'Academie Nationale De Medecine
|November 1, 1993
PubMed
Summary

The pneumococcal vaccine effectively reduces pneumonia incidence, especially in high-risk groups. Increased vaccination is recommended for better public health outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bacteroides fragilis group infections in HIV-infected patients. The Bacteroides Study Group.

AIDS patient care and STDs·2001
Same author

Screening of Chlamydia trachomatis genital infection in a young Parisian population.

Sexually transmitted infections·1999
Same author

[Emergency consultations of foreign tourists in Paris in the month of August. 5 years of prospective surveillance (1992-1996)].

Bulletin de la Societe de pathologie exotique (1990)·1999
Same author

Malaria chemoprophylaxis of 3,446 French travelers departing from Paris to eight tropical countries.

Journal of travel medicine·1999
Same author

A rare case of cotrimoxazole-induced eosinophilic aseptic meningitis in an HIV-infected patient.

Scandinavian journal of infectious diseases·1999
Same author

Health hazards in international tourists visiting Paris in August: a five-year retrospective epidemiologic survey.

Journal of travel medicine·1999

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Context:

  • The pneumococcal vaccine, available since 1977, has low uptake in France.
  • Pneumococcal pneumonia poses a significant life-threatening risk, particularly in certain demographics.

Purpose:

  • To evaluate the efficacy of the pneumococcal vaccine in preventing pneumococcal pneumonia.
  • To assess the vaccine's effectiveness across different population groups, including immunocompromised individuals.

Summary:

  • Epidemiological studies confirm the pneumococcal vaccine's high efficacy in lowering pneumonia incidence.
  • Vaccine effectiveness is substantial, though potentially reduced in immunocompromised subjects.

Impact:

  • The findings support stronger recommendations for pneumococcal immunisation practices.

Related Experiment Videos

  • Enforcing vaccination guidelines can significantly improve public health by reducing pneumonia burden.